STX-0712
Asset
Depletes disease-driving CCR2-positive malignant monocytes and bone marrow progenitors.
- Stage
- Phase 1
- Modality
- Other
- Target
- CCR2
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Acute myeloid leukemia
Phase 1, globenewswire.com, 8 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
Every asset’s record: target, stage, trials and the evidence behind it.